# Ensysce Biosciences, Inc.: filings

ENSC · Nasdaq · CIK 1716947 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ensc.md) · [Financials](/companies/ensc/financials.md) · [Filings](/companies/ensc/filings.md) · [Insiders](/companies/ensc/insiders.md)

## Reports and events: 209 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 125, 4 46, 425 35, CORRESP 31, 424B3 29, 10-Q 27, 3 24, UPLOAD 22, EFFECT 21, DEFA14A 15, S-1/A 14, SC 13G 14, DEF 14A 13, S-3 13, PRE 14A 11, SC 13G/A 11, 10-K 9, D 8, S-1 7, S-4/A 6, SCHEDULE 13G/A 6, 424B5 5, S-8 5, SC 13D 5, 424B8 4, 424B4 3, 8-K/A 3, POS AM 3, SC 13D/A 3, 10-K/A 2, 8-A12G/A 2, ARS 2, POS EX 2, SEC STAFF LETTER 2, 8-A12B 1, 8-A12G 1, AW 1, CERTNAS 1, DEL AM 1, DRS 1, NT 10-Q 1, PREM14A 1, PRER14A 1, RW 1, S-3/A 1, S-4 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 21:56 ET | [8-K/A](/filings/0001493152-26-047317.md) | 9.01 Financial statements and exhibits | 0001493152-26-047317 |
| 2026-09-29 | 08:31 ET | [8-K](/filings/0001493152-26-044802.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-044802 |
| 2026-08-25 | 17:12 ET | [8-K](/filings/0001493152-26-040080.md) | 8.01 Other events | 0001493152-26-040080 |
| 2026-08-24 | 17:13 ET | [8-K](/filings/0001493152-26-039898.md) | 8.01 Other events | 0001493152-26-039898 |
| 2026-08-18 | 12:30 ET | [SCHEDULE 13D/A](/filings/0001493152-26-038943.md) | Ownership report, active investor, amended | 0001493152-26-038943 |
| 2026-08-13 | 16:31 ET | [10-Q](/filings/0001493152-26-037817.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037817 |
| 2026-08-13 | 16:20 ET | [8-K](/filings/0001493152-26-037794.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037794 |
| 2026-08-06 | 15:45 ET | [8-K/A](/filings/0001493152-26-036326.md) | 9.01 Financial statements and exhibits | 0001493152-26-036326 |
| 2026-08-06 | 08:20 ET | [8-K](/filings/0001493152-26-036268.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036268 |
| 2026-07-15 | 16:15 ET | [8-K](/filings/0001493152-26-033360.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-033360 |
| 2026-05-22 | 16:55 ET | [8-K](/filings/0001493152-26-025061.md) | 3.01 Delisting notice | 0001493152-26-025061 |
| 2026-05-15 | 16:20 ET | [10-Q](/filings/0001493152-26-023811.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023811 |
| 2026-05-15 | 16:20 ET | [8-K](/filings/0001493152-26-023810.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-023810 |
| 2026-04-08 | 21:05 ET | [8-K](/filings/0001493152-26-015602.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-015602 |
| 2026-04-03 | 16:14 ET | [8-K](/filings/0001493152-26-015139.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-015139 |
| 2026-03-30 | 17:38 ET | [10-K](/filings/0001493152-26-013633.md) | Annual report, period 2025-12-31 | 0001493152-26-013633 |
| 2026-03-30 | 17:37 ET | [8-K](/filings/0001493152-26-013622.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-013622 |
| 2026-03-30 | 17:47 ET | [8-K](/filings/0001493152-26-013314.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-013314 |
| 2026-03-23 | 08:00 ET | [8-K](/filings/0001493152-26-012062.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-012062 |
| 2026-02-27 | 16:30 ET | [8-K](/filings/0001493152-26-008343.md) | 3.01 Delisting notice | 0001493152-26-008343 |
| 2026-01-08 | 17:14 ET | [8-K](/filings/0001493152-26-000994.md) | 5.07 Shareholder vote results | 0001493152-26-000994 |
| 2025-12-02 | 13:26 ET | [DEF 14A](/filings/0001493152-25-025696.md) | Proxy statement, period 2025-12-02 | 0001493152-25-025696 |
| 2025-11-17 | 17:29 ET | [8-K](/filings/0001493152-25-023933.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-023933 |
| 2025-11-14 | 16:16 ET | [10-Q](/filings/0001493152-25-023498.md) | Quarterly report, period 2025-09-30 | 0001493152-25-023498 |
| 2025-11-14 | 16:15 ET | [8-K](/filings/0001493152-25-023492.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-023492 |
| 2025-08-13 | 16:30 ET | [10-Q](/filings/0001641172-25-023512.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023512 |
| 2025-08-13 | 16:20 ET | [8-K](/filings/0001641172-25-023500.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023500 |
| 2025-06-05 | 17:02 ET | [8-K](/filings/0001641172-25-013853.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-013853 |
| 2025-05-13 | 16:20 ET | [10-Q](/filings/0001641172-25-009955.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009955 |
| 2025-05-13 | 16:15 ET | [8-K](/filings/0001641172-25-009949.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009949 |
| 2025-04-24 | 16:27 ET | [8-K](/filings/0001641172-25-006009.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-006009 |
| 2025-04-01 | 16:30 ET | [8-K](/filings/0001641172-25-002087.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-002087 |
| 2025-03-31 | 16:20 ET | [8-K](/filings/0001641172-25-001751.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-001751 |
| 2025-03-10 | 16:20 ET | [10-K](/filings/0001493152-25-009703.md) | Annual report, period 2024-12-31 | 0001493152-25-009703 |
| 2025-03-10 | 16:15 ET | [8-K](/filings/0001493152-25-009695.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-009695 |
| 2025-02-04 | 17:29 ET | [8-K](/filings/0001493152-25-004880.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-004880 |
| 2024-12-03 | 16:15 ET | [8-K](/filings/0001493152-24-048497.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-048497 |
| 2024-11-21 | 16:15 ET | [8-K](/filings/0001493152-24-047149.md) | 5.07 Shareholder vote results | 0001493152-24-047149 |
| 2024-11-12 | 16:20 ET | [10-Q](/filings/0001493152-24-044768.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044768 |
| 2024-11-12 | 16:15 ET | [8-K](/filings/0001493152-24-044760.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044760 |
| 2024-10-18 | 16:56 ET | [8-K](/filings/0001493152-24-041589.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-041589 |
| 2024-10-18 | 21:34 ET | [DEF 14A](/filings/0001493152-24-041470.md) | Proxy statement, period 2024-10-17 | 0001493152-24-041470 |
| 2024-08-30 | 20:54 ET | [8-K](/filings/0001493152-24-034451.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-034451 |
| 2024-08-23 | 16:30 ET | [8-K](/filings/0001493152-24-033731.md) | 3.01 Delisting notice | 0001493152-24-033731 |
| 2024-08-14 | 16:32 ET | [8-K](/filings/0001493152-24-032272.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-032272 |
| 2024-08-14 | 16:30 ET | [10-Q](/filings/0001493152-24-032263.md) | Quarterly report, period 2024-06-30 | 0001493152-24-032263 |
| 2024-05-28 | 08:10 ET | [8-K](/filings/0001493152-24-021456.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-021456 |
| 2024-05-13 | 08:10 ET | [8-K](/filings/0001493152-24-018793.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-018793 |
| 2024-05-13 | 18:08 ET | [10-Q](/filings/0001493152-24-018718.md) | Quarterly report, period 2024-03-31 | 0001493152-24-018718 |
| 2024-05-09 | 16:40 ET | [8-K](/filings/0001493152-24-018482.md) | 8.01 Other events | 0001493152-24-018482 |

Page 1 of 5. [Older](/companies/ensc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:37 ET. No prices; not investment advice.